Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133:1703–14.

Article  CAS  PubMed Central  Google Scholar 

Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Cutaneous T cell lymphoma. Nat Rev Dis Primers. 2021. https://doi.org/10.1038/S41572-021-00296-9.

Dobos G, de Masson A, Ram-Wolff C, et al. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry. Br J Dermatol. 2021;184:1059–67.

Article  CAS  PubMed  Google Scholar 

Weed J, Girardi M. The difficult—and often delayed—diagnosis of CTCL. Sci Transl Med. 2015. https://doi.org/10.1126/SCITRANSLMED.AAD2518.

Scarisbrick JJ, Quaglino P, Prince HM, et al. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol. 2019;181:350–7.

Article  CAS  PubMed  Google Scholar 

Mehta-Shah N, Horwitz SM, Ansell S, et al. NCCN guidelines insights: primary cutaneous lymphomas, version 2.2020: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2020;18:522–36.

Article  PubMed  Google Scholar 

Maredia H, Cozzio A, Dummer R, Ramelyte E, Kim EJ, Rozati S. Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome. JAAD Case Rep. 2021;15:92–6.

Article  PubMed  PubMed Central  Google Scholar 

Scarisbrick JJ. The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas. Presse Med. 2022. https://doi.org/10.1016/J.LPM.2022.104123.

Hodak E, Sherman S, Papadavid E, et al. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. Br J Dermatol. 2021;184:524–31.

Article  CAS  PubMed  Google Scholar 

Scarisbrick J, Kim Y. Prognostic factors in mycosis fungoides and Sezary syndrome: results from the PROCLIPI study. Eur J Cancer. 2022;173:S18.

Article  Google Scholar 

Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713–22.

Article  CAS  PubMed  Google Scholar 

Scarisbrick JJ, Hodak E, Bagot M, et al. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. Eur J Cancer. 2018;93:47–56.

Article  PubMed  Google Scholar 

Vermeer MH, Moins-Teisserenc H, Bagot M, Quaglino P, Whittaker S. Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach. Br J Dermatol. 2022;187:21–8.

Article  PubMed  Google Scholar 

Kalina T, Flores-Montero J, Van Der Velden VHJ, et al (2012) EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012 26:9 26:1986–2010.

Najidh S, Tensen CP, van der Sluijs-Gelling AJ, et al. Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome. Blood. 2021;138:2539–54.

Article  CAS  PubMed  Google Scholar 

Kim EJ, Hess S, Richardson SK, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005;115:798–812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodney IJ, Kindred C, Angra K, Qutub ON, Villanueva AR, Halder RM. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study. J Eur Acad Dermatol Venereol. 2017;31:808–14.

Article  CAS  PubMed  Google Scholar 

Furlan FC, Sanches JA. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology. An Bras Dermatol. 2013;88:954–60.

Article  PubMed  PubMed Central  Google Scholar 

Villarreal AM, Gantchev J, Lagacé F, Barolet A, Sasseville D, Ødum N, Charli-Joseph YV, Salazar AH, Litvinov IV. Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients. Cancers (Basel). 2020;12:1–21.

Google Scholar 

Cao S, Kruglov O, Akilov OE. CD8+ T lymphocytes in hypopigmented mycosis fungoides: malignant cells or reactive clone? Journal of Investigative Dermatology. 2023;143:521–524.e3.

Article  CAS  PubMed  Google Scholar 

van Doorn R, Scheffer E, Willemze R. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol. 2002. https://doi.org/10.1001/ARCHDERM.138.2.191.

Van Santen S, Roach REJ, Van Doorn R, et al. Clinical staging and prognostic factors in Folliculotropic Mycosis Fungoides. JAMA Dermatol. 2016;152:992–1000.

Article  PubMed  Google Scholar 

Hodak E, Amitay-Laish I, Atzmony L, Prag-Naveh H, Yanichkin N, Barzilai A, Kershenovich R, Feinmesser M. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience. J Am Acad Dermatol. 2016;75:347–55.

Article  PubMed  Google Scholar 

Mitteldorf C, Stadler R, Sander CA, Kempf W. Folliculotropic mycosis fungoides. JDDG. Journal der Deutschen Dermatologischen Gesellschaft. 2018;16:543–57.

Article  PubMed  Google Scholar 

Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.

Article  CAS  PubMed  Google Scholar 

Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov I V., Iversen L, Langhoff E, Woetmann A, Odum N (2016) Malignant inflammation in cutaneous T-cell lymphoma—a hostile takeover. Seminars in Immunopathology 2017 39:3 39:269–282.

Guenova E, Watanabe R, Teague JE, et al. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res. 2013;19:3755–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Durgin JS, Weiner DM, Wysocka M, Rook AH. The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Part I, pathways and targets for immune restoration and tumor eradication. J Am Acad Dermatol. 2021;84:587.

Article  CAS  PubMed  Google Scholar 

Querfeld C, Leung S, Myskowski PL, et al. Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile. Cancer Immunol Res. 2018;6:900–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gluud M, Pallesen EMH, Buus TB, et al. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma. Blood. 2023;141:180–93.

Article  CAS  PubMed  Google Scholar 

Kalliara E, Belfrage E, Gullberg U, Drott K, Ek S (2023) Spatially guided and single cell tools to map the microenvironment in cutaneous T-cell lymphoma. Cancers 2023, Vol 15, Page 2362 15:2362.

Blümel E, Willerslev-Olsen A, Gluud M, et al. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma. Oncoimmunology. 2019. https://doi.org/10.1080/2162402X.2019.1641387/SUPPL_FILE/KONI_A_1641387_SM3398.ZIP.

Tegla CA, Herrera AM, Seffens AM, et al. Skin associated staphylococcus aureus contributes to disease progression in CTCL. Blood. 2019;134:659.

Article  Google Scholar 

Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, et al. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma. Blood. 2019;134:1072–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Emge DA, Bassett RL, Duvic M, Huen AO. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Arch Dermatol Res. 2020;312:283–8.

Article  CAS  PubMed  Google Scholar 

Dehner CA, Ruff WE, Greiling T, Pereira MS, Redanz S, McNiff J, Girardi M, Kriegel MA. Malignant T cell activation by a bacillus species isolated from cutaneous t-cell lymphoma lesions. JID Innov. 2022;2:100084.

Article  PubMed  Google Scholar 

Stowman AM, Hsia LL, Kanner WA, Mahadevan MS, Bullock GC, Patterson JW. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature. Int J Dermatol. 2016;55:e62–71.

Article  CAS  PubMed  Google Scholar 

Hamrouni A, Fogh H, Zak Z, Odum N, Gniadecki R. Clonotypic diversity of the T-cell receptor corroborates the immature precursor origin of cutaneous T-cell lymphoma. Clin Cancer Res. 2019;25:3104–14.

Article  CAS  PubMed  Google Scholar 

Iyer A, Hennessey D, O’Keefe S, Patterson J, Wang W, Wong GKS, Gniadecki R. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma. Blood. 2019;134:1517–27.

Article  PubMed  Google Scholar 

Klicznik MM, Morawski PA, Höllbacher B, et al. Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy individuals. Sci Immunol. 2019;4:8995.

Article  Google Scholar 

Iyer A, Hennessey D, O’Keefe S, Patterson J, Wang W, Wong GKS, Gniadecki R. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma. Blood Adv. 2020;4:2489–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herrera A, Cheng A, Mimitou EP, et al. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures. Blood. 2021;138:1456–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Jin S, Hu S, et al. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma. Nature Communications. 2022;13:1–18.

Google Scholar 

Peiffer L, Gambichler T, Buus TB, et al. Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcripto